Showing results (811-820 of 1,122) with videos related to
Sort By:
Pageof 113
Cancer Genetics|May 22, 2026
ISG15 drives cervical cancer progression by hyperactivating the NOD-like receptor signaling pathwayZongyang Jia, Junhua Zhang, Xiaoli Liu, et al.Cancer Genetics|June 9, 2026
Acquired ring chromosomes in hematological malignancies: A systematic evidence review for diagnostic advances, cytogenomic insights, and clinical significance by an International Consortium on Human Ring Chromosomes (ICHRC) working groupMaged Zeineldin, Jaclyn B Murry, Dhanlaxmi Shetty, et al.Cancer Genetics|March 19, 2026
Association of high and moderate penetrance monogenic variants, polygenic risk, and family history with breast cancer in an ancestrally diverse populationEmily R Soper, Nicole A Casasanta, Bethany Dubois, et al.Cancer Genetics|July 7, 2023
Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinomaMei Ling Chong, James Knight, Gang Peng, et al.Cancer Genetics|April 8, 2026
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic optionsNuwar Harb, Marcel Romey, Albert Grass, et al.Cancer Genetics|May 9, 2026
CRYL1 inhibits tumorigenesis and metastasis in clear cell renal cell carcinoma through upregulation of CASRYipeng Xu, Peng Li, Xigao Liu, et al.Cancer Genetics|July 11, 2026
Germline pathogenic PTEN variant in a patient with a Kaposiform haemangioendotheliomaHannah Massey, Karim El Shakankery, Stefan N Symeonides, et al.Cancer Genetics|July 9, 2026
Evolution of germline testing, mutation spectrum and clinico-pathological features in male breast cancer: a 27-year retrospective cohort including 69 patientsNicolas Taris, Nile Duflos De Saint Amand, Carole Hild, et al.Cancer Genetics|July 7, 2026
Clinical utility and implementation of a virtual molecular tumor board in real-world oncology practiceOlesya Kuznetsova, Maria Cheporova, Madina Khagazheeva, et al.Cancer Genetics|August 22, 2026
From genotype to outcome in optic pathway gliomas: Biology, biomarkers, targeted therapy, and future directionsEduardo Jahir Angulo-De La Cruz, Galilea Magaña-Curiel, Rafel Luis Aguirre-Guillén, et al.Pageof 113